文献速递类风湿关节炎

多组学整合识别关节痛向类风湿关节炎进展相关生物标志物

Integrative Multiomics Approaches Identify Biomarkers Associated With Progression From Arthralgia to Rheumatoid Arthritis.
PubMed 文献 · Arthritis Rheumatol · 2026-04-20

研究纳入346例新发关节痛患者,整合外周免疫细胞表型、血清蛋白质组与自身抗体谱,追踪关节痛向类风湿关节炎(RA)的免疫病理连续谱。24个月内18.4%的RA高危关节痛者进展为RA,Treg细胞及Treg/Th17比值下降与进展相关。

要点

  • Treg/Th17比值区分高危关节痛与自限性关节痛优于抗CCP(AUC 0.734对0.611)。
  • 抗CCP阴性者中Treg/Th17比值AUC为0.729,三联组合AUC达0.783。
  • 24个月内18.4%的RA高危关节痛者进展为RA,进展者随访中Treg下降。

核心结论

  • 关节痛向RA进展涉及从可逆免疫失调到确立自身免疫的连续过程,Treg相关失调可能与持续炎症性关节炎进展相关。

研究设计与样本

  • 前瞻性队列纳入346例新发关节痛患者,含健康对照、自限性关节痛、RA高危关节痛、早期RA与确立RA,整合外周免疫细胞表型、血清蛋白质组和自身抗体谱,高危者随访24个月确定RA发生。

主要发现

  • 与自限性关节痛相比,RA高危者Treg细胞减少、Treg/Th17比值降低,并延续至早期RA。
  • 血清C5、α-1B糖蛋白、RPUSD4、WDR87、FUBP2上调且与Treg细胞呈负相关。
  • RA高危者应激相关蛋白抗体升高,自身抗体反应呈阶段特异性。
  • 24个月内18.4%的RA高危者进展为RA,进展者与非进展者基线免疫表型差异相当,纵向配对分析显示Treg细胞及Treg/Th17比值下降。

关键数值与推荐

  • Treg/Th17比值区分RA高危与自限性关节痛的AUC为0.734,抗CCP为0.611。
  • 抗CCP阴性者中Treg/Th17比值AUC为0.729。
  • Treg细胞、抗CCP与Treg/Th17比值联合的AUC为0.783。

临床怎么用

  • 对RA高危关节痛者可检测Treg/Th17比值辅助风险分层,抗CCP阴性者亦可参考,联合抗CCP可提升区分效能。

局限性

  • 进展者与非进展者基线免疫表型差异相当,标志物的预测价值需更多验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Arthralgia, an early manifestation preceding definite rheumatoid arthritis (RA), represents a critical window to identify high-risk individuals and implement timely interventions. However, the immunopathologic mechanisms underlying the transition from arthralgia to established RA remain incompletely defined. METHODS: We employed a multiomics strategy integrating peripheral immune cell phenotyping, serum proteomics, and autoantibody profiling to investigate the immunopathologic continuum from preclinical to established RA. A prospective cohort of 346 patients with recent-onset arthralgia was enrolled. Participants included healthy controls, self-limiting arthralgia (SLA), arthralgia at risk of RA (at-risk individuals, ARI), early RA, and established RA. RA development in ARI was ascertained through 24-month follow-up. RESULTS: Compared with SLA, ARI showed immune dysregulation, including reduced Treg cells and a lower Treg/Th17 cell ratio, with related changes persisting into early RA. Serum proteomics revealed upregulation of C5, α-1-B glycoprotein, RPUSD4, WDR87, and FUBP2, which showed inverse associations with Treg cells. Autoantibody profiling identified stage-specific reactivity, with ARI showing elevated antibodies against stress-related proteins. Within 24 months, 18.4% of ARI progressed to RA (converters). Baseline immunophenotypic differences between converters and nonconverters were comparable, whereas longitudinal paired analyses revealed a reduction in Treg cells and Treg/Th17 cell ratio. Treg/Th17 cell ratio (area under the curve [AUC] 0.734) outperformed anti-cyclic citrullinated peptide (CCP; AUC 0.611) in discriminating ARI from SLA, particularly in patients who are anticitrullinated peptide antibodies negative (AUC 0.729). Combining Treg cells, anti-CCP and Treg/Th17 cell ratio improved classification performance (AUC 0.783). CONCLUSION: These findings delineate a critical transition from reversible immune dysregulation to established autoimmunity along the arthralgia-RA continuum, suggesting that Treg cell-related dysregulation may be associated with progression toward persistent inflammatory arthritis.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Li M, Han Y, Zhan M, et al. Integrative Multiomics Approaches Identify Biomarkers Associated With Progression From Arthralgia to Rheumatoid Arthritis. Arthritis Rheumatol. 2026. PMID: 42010917. doi:10.1002/art.70194

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。